Norfenefrine
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Other names | Norfenephrine Norphenephrine Norphenylephrine meta-Norsynephrine meta-Octopamine 3-Octopamine |
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Metabolism | m-hydroxymandelic acid |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.007.844 |
| Chemical and physical data | |
| Formula | C8H11NO2 |
| Molar mass | 153.181 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
|
| |
Norfenefrine (INN; also known as meta-octopamine, 3-octopamine, and 3,β-dihydroxyphenethylamine) is an adrenergic agent used as a sympathomimetic drug which is marketed in Europe, Japan, and Mexico. Along with its structural isomer p-octopamine and the tyramines, norfenefrine is a naturally occurring, endogenous trace amine and plays a role as a minor neurotransmitter in the brain.
Some brand names for it include Coritat, Energona, Hypolind, and Novadral.
See also
|
Cardiac stimulants excluding cardiac glycosides (C01C)
| |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adrenergic and dopaminergic agents |
|
||||||||||||||
| Phosphodiesterase inhibitors (PDE3I) | |||||||||||||||
| Other cardiac stimulants | |||||||||||||||
| |||||||||||||||
| Amino acid-derived |
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lipid-derived |
|
||||||||||||||||||||||
| Nucleobase-derived |
|
||||||||||||||||||||||
| Vitamin-derived |
|
||||||||||||||||||||||
| Miscellaneous |
|
||||||||||||||||||||||
| TAAR1 |
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TAAR2 |
|
||||||||||
| TAAR5 |
|
||||||||||
† References for all endogenous human TAAR1 ligands are provided at List of trace amines
‡ References for synthetic TAAR1 agonists can be found at TAAR1 or in the associated compound articles. For TAAR2 and TAAR5 agonists and inverse agonists, see TAAR for references.
| |||||||||||
| Phenethylamines |
|
|---|---|
| Amphetamines |
|
| Phentermines |
|
| Cathinones |
|
| Phenylisobutylamines | |
| Phenylalkylpyrrolidines | |
|
Catecholamines |
|
| Miscellaneous |
|